$COSM SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion
16 Oct 2026	SCHEDULE 13G/A
09 Oct 2026	8-K: Results of Operations and Financial Condition Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
20 Aug 2026	8-K: Results of Operations and Financial Condition
18 Aug 2026	FORM 10-Q
14 Aug 2026	NT 10-Q
31 Jul 2026	Form 4: Siokas Grigorios, Director Bought 349,825 shares ($70K)
30 Jul 2026	Form 4: Terzis Georgios, Chief Financial Officer Received 328,407 shares as a grant or award ($60K)
30 Jul 2026	Form 4: Siokas Grigorios, Director Bought 766,284 shares ($140K)
22 Jul 2026	RW
17 Jul 2026	FORM S-8
16 Jul 2026	8-K: Material Modification to Rights of Security Holders; Departure/Election of Directors or Officers; Compensation +2 more
06 Jul 2026	8-K: Regulation FD Disclosure; Other Events
17 Jun 2026	Form 4: Terzis Georgios, Chief Financial Officer Bought 168,135 shares ($42K)
12 Jun 2026	Form 4: Siokas Grigorios, Director Bought 218,447 shares ($45K)
12 Jun 2026	Form 4: Siokas Grigorios, Director Bought 701,447 shares ($160K)
11 Jun 2026	Form 4: Karkantzos Theodoros Christos, Director Received 20,000 shares as a grant or award ($5.66K) · Converted 35,000 Restricted Stock Unit
11 Jun 2026	Form 4: Hoidas John James, Director Received 20,000 shares as a grant or award ($5.66K) · Converted 20,000 Restricted Stock Unit
11 Jun 2026	Form 4: Demetriades Demetrios G., Director Received 20,000 shares as a grant or award ($5.66K) · Converted 20,000 Restricted Stock Unit
11 Jun 2026	Form 4: Aslidis Anastasios, Director Received 40,000 shares as a grant or award ($11.3K) · Converted 40,000 Restricted Stock Unit

Comments